Radix morindae officinalis polysaccharide-synanthrin composite gel as well as preparation method and application thereof
Through the multi-target effect of Morinacea polysaccharide-inulin complex gel, the problems of intestinal homeostasis reconstruction and drug transport in the treatment of renal fibrosis were solved, effective interventions in intestinal barrier repair and renal fibrosis were achieved, and safe and efficient treatment plans were provided.
Patent Information
- Application Number
- CN202510971824.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-15
- Publication Date
- 2025-08-12
- Estimated Expiration
- 2045-07-15
AI Technical Summary
Existing therapeutic strategies are difficult to achieve effective intervention in renal fibrosis, especially in terms of challenges in intestinal homeostasis reconstruction and long-term remission, and the transport process of drugs in the gastrointestinal tract faces complex environmental impacts, affecting drug stability and absorption effect.
It provides a Morinacea polysaccharide-inulin complex gel composed of Morinacea polysaccharide, inulin and water. It achieves multi-target effects through a composite design, which can regulate immune response and intestinal microbiota, interfere with intestinal barriers and renal fibrosis.
This composite gel has good biocompatibility and safety, and can intervene at the same time against intestinal microenvironment and renal fibrosis, significantly improve the therapeutic effect, provide new treatment options, and fill the gap in existing treatment methods.